Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections

N. A. Halsey; P. J. Chesney; M. A. Gerber; D. S. Gromisch; S. Kohl; S. M. Marcy; M. I. Marks; Dennis L Murray; J. C. Overall; L. K. Pickering; R. J. Whitley; R. Yogev; G. Peter; R. L. Berkelman; M. C. Hardgree; R. F. Jacobs; N. E. MacDonald; W. A. Orenstein; N. R. Rabinovich

Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections

N. A. Halsey, P. J. Chesney, M. A. Gerber, D. S. Gromisch, S. Kohl, S. M. Marcy, M. I. Marks, Dennis L Murray, J. C. Overall, L. K. Pickering, R. J. Whitley, R. Yogev, G. Peter, R. L. Berkelman, M. C. Hardgree, R. F. Jacobs, N. E. MacDonald, W. A. Orenstein, N. R. Rabinovich

Pediatrics

Research output: Contribution to journal › Review article › peer-review

188 Scopus citations

Abstract

The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.

Original language	English (US)
Pages (from-to)	137-140
Number of pages	4
Journal	Pediatrics
Volume	97
Issue number	1
State	Published - Jan 1 1996

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Cite this

Halsey, N. A., Chesney, P. J., Gerber, M. A., Gromisch, D. S., Kohl, S., Marcy, S. M., Marks, M. I., Murray, D. L., Overall, J. C., Pickering, L. K., Whitley, R. J., Yogev, R., Peter, G., Berkelman, R. L., Hardgree, M. C., Jacobs, R. F., MacDonald, N. E., Orenstein, W. A., & Rabinovich, N. R. (1996). Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics, 97(1), 137-140.

Halsey, NA, Chesney, PJ, Gerber, MA, Gromisch, DS, Kohl, S, Marcy, SM, Marks, MI, Murray, DL, Overall, JC, Pickering, LK, Whitley, RJ, Yogev, R, Peter, G, Berkelman, RL, Hardgree, MC, Jacobs, RF, MacDonald, NE, Orenstein, WA & Rabinovich, NR 1996, 'Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections', Pediatrics, vol. 97, no. 1, pp. 137-140.

@article{af5ae43c265c45eb932cb13178869e60,

title = "Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections",

abstract = "The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.",

author = "Halsey, {N. A.} and Chesney, {P. J.} and Gerber, {M. A.} and Gromisch, {D. S.} and S. Kohl and Marcy, {S. M.} and Marks, {M. I.} and Murray, {Dennis L} and Overall, {J. C.} and Pickering, {L. K.} and Whitley, {R. J.} and R. Yogev and G. Peter and Berkelman, {R. L.} and Hardgree, {M. C.} and Jacobs, {R. F.} and MacDonald, {N. E.} and Orenstein, {W. A.} and Rabinovich, {N. R.}",

year = "1996",

month = jan,

day = "1",

language = "English (US)",

volume = "97",

pages = "137--140",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "1",

}

TY - JOUR

T1 - Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections

AU - Halsey, N. A.

AU - Chesney, P. J.

AU - Gerber, M. A.

AU - Gromisch, D. S.

AU - Kohl, S.

AU - Marcy, S. M.

AU - Marks, M. I.

AU - Murray, Dennis L

AU - Overall, J. C.

AU - Pickering, L. K.

AU - Whitley, R. J.

AU - Yogev, R.

AU - Peter, G.

AU - Berkelman, R. L.

AU - Hardgree, M. C.

AU - Jacobs, R. F.

AU - MacDonald, N. E.

AU - Orenstein, W. A.

AU - Rabinovich, N. R.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.

AB - The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.

UR - http://www.scopus.com/inward/record.url?scp=2442671303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442671303&partnerID=8YFLogxK

M3 - Review article

C2 - 8545210

AN - SCOPUS:2442671303

SN - 0031-4005

VL - 97

SP - 137

EP - 140

JO - Pediatrics

JF - Pediatrics

IS - 1

ER -

Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this